ChemoTech: Outcome Of Directed Issue

About this update from Scandinavian Chemotech Ab Class B

Scandinavian ChemoTech AB OMXSTO:CMOTEC_B:CHEMOTECH ANNOUNCES OUTCOME OF THE DIRECTED ISSUEISSUES 761,191 NEW CLASS A SHARES TOTALING ABOUT SEK 2.55 MILLIONSUBSCRIPTION PRICE SET AT SEK 3.35 PER CLASS A SHARE, 10% DISCOUNT TO VWAP

View stock analysis, news, and events for Scandinavian Chemotech Ab Class B